Form D · Biotechnology

Bamboo Therapeutics, Inc.

Chapel Hill, NC · CIK 0001666110

Offering snapshot reported Feb 11, 2016 · SEC filing

Reported sold
$49.5M
Offering amount: $49.5M
Investors reported
6
Form D · investor count
Minimum accepted
$300K
Reported outside-investor minimum
First sale
Jan 29, 2016
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$24.7M$49.5MFeb 11, 2016: $49,467,472.00Feb 11, 2016Feb 11, 2016: $49,467,472.00Feb 11, 2016

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 11, 2016Initial$49,467,472No comparison6SEC filing
Feb 11, 2016Amendment$49,467,472$0vs Feb 11, 20166SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$3.02M
Finders' fees
$0
Form D file number
021-257284

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Piper Jaffray & Co.665

Source: Form D, filed Feb 11, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Michael Goettler Director
Sheila Mikhail Director, Executive
Richard Jude Samulski Director, Executive
Robert Smith Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
870 Martin Luther King, Jr. Blvd.
Chapel Hill, NC, 27514